Pushing Forward in Prostate Cancer Research

Almost everyone knows somebody living with prostate cancer.

The people we know are not just a statistic or a number. They are husbands, fathers, sons and brothers. They are families fighting to hang on to their dreams for the future. And that’s what we’re fighting for – aggressively building our prostate cancer research program to help advance new treatments for men who are running out of options.

“At Merck, we are passionate about fighting cancer and focusing on tumors and populations that have traditionally been underserved. I’m proud to be part of a large team working to bring hope to men and their families who are courageously fighting advanced prostate cancer.”
-Markus Puhlmann, associate vice president, section head genitourinary, oncology clinical development

When prostate cancer is caught early, it generally has a better survival rate. But, for those men diagnosed with locally advanced or metastatic prostate cancer, the outcomes can be dramatically different. At Merck, we are focused on trying to do more for these men.

“We are in the midst of building one of the largest and most comprehensive research programs in prostate cancer in the industry. Our goal is to find new treatment approaches across all settings of prostate cancer where there is tremendous need for new therapies.”

About Prostate Cancer

  • In the U.S., prostate cancer is the second leading cause of cancer death in men, behind lung cancer.
  • About 1 in 9 men will be diagnosed with prostate cancer during his lifetime.
  • The risk of prostate cancer is 74% higher in African Americans.
  • The average age at diagnosis is about 66.